semaglutide and vertigo GLP-1 meds like (Ozempic/Wegovy) tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk Understanding Vertigo as a Rare
Description
It belongs to a class of medications known as GLP-1 receptor agonists, which mimic the natural hormone glucagon-like peptide-1, a key messenger in your bodys appetite and metabolism systems
Afterward, you may experience redness, itching, and / or swelling at the injection site

Body Mass Index as a Phenotypic Expression of Adiposity: Quantitative Contribution of Muscularity in a Population-Based Sample

Participants on the 12 mg dose reported an average weight loss of 28.3%, with over 45% achieving a 30% reduction

Catagen (Transition Phase): Lasts 2-3 weeks

This bespoke approach can enhance treatment efficacy, reduce side effects, and offer a more accessible option for patients seeking effective weight loss
